Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0090
+0.0074
+(462.50%)
As of February 26 at 1:27:01 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,284
-13,437
-19,452
-23,664
-25,315
Investing Cash Flow
-12
-15
197
-279
-291
Financing Cash Flow
10,090
11,595
3,079
29,361
19,958
End Cash Position
2,309
4,469
6,326
22,502
17,084
Capital Expenditure
-12
-15
-13
-279
-291
Issuance of Capital Stock
10,418
11,549
4,253
32,233
20,246
Issuance of Debt
--
--
--
--
547
Repayment of Debt
-928
-797
-1,174
-3,872
-3,776
Free Cash Flow
-15,296
-13,452
-19,465
-23,943
-25,606
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OMGAQ
0.0260
-16.13%
NAVB Navidea Biopharmaceuticals, Inc.
0.0009
0.00%
DBVT DBV Technologies S.A.
4.0350
-4.61%
NBY NovaBay Pharmaceuticals, Inc.
0.6048
-0.87%
EPIX ESSA Pharma Inc.
1.6650
-0.89%
COEP Coeptis Therapeutics Holdings, Inc.
10.45
-0.95%
VIRX Viracta Therapeutics, Inc.
0.0230
+5.02%
DRMA Dermata Therapeutics, Inc.
1.1110
-4.23%
VINC Vincerx Pharma, Inc.
1.0904
-13.46%
TECX Tectonic Therapeutic, Inc.
25.79
+0.84%